Researcher Profiles

Return to member profile

Stavroula Sofou, PhD

Publications since 2011

Bandekar, A. Zhu, C. Jindal, R. Bruchertseifer, F. Morgenstern, A. Sofou, S. Anti-Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular alpha-Particle Therapy of Cancer. J Nucl Med, 55:107-114, . (PMID: 24337602)

Sunderram, J. Sofou, S. Kamisoglu, K. Karantza, V. Androulakis, I. P. Time-restricted feeding and the realignment of biological rhythms: translational opportunities and challenges. J Transl Med, 12:79, . (PMID: 24674294, PMCID: PMC3973614)

Sempkowski, M. Locke, T. Stras, S. Zhu, C. Sofou, S. Liposome-based approaches for delivery of mainstream chemotherapeutics: preparation methods, liposome designs, therapeutic efficacy. Crit Rev Oncog, 19:177-221, . (PMID: 25271431)

Bandekar, A. Zhu, C. Gomez, A. Menzenski, M. Z. Sempkowski, M. Sofou, S. Masking and triggered unmasking of targeting ligands on liposomal chemotherapy selectively suppress tumor growth in vivo. Mol Pharm, 10:152-160, . (PMID: 23134440)

Bandekar, A. Karve, S. Chang, M. Y. Mu, Q. Rotolo, J. Sofou, S. Antitumor efficacy following the intracellular and interstitial release of liposomal doxorubicin. Biomaterials, 33:4345-4352, . (PMID: 22429980)

Bhagat, M. Halligan, S. Sofou, S. Nanocarriers to solid tumors: considerations on tumor penetration and exposure of tumor cells to therapeutic agents. Curr Pharm Biotechnol, 13:1306-1316, . (PMID: 22201591)

Bandekar, A. Sofou, S. Floret-shaped solid domains on giant fluid lipid vesicles induced by pH. Langmuir, 28:4113-4122, . (PMID: 22276950)

Mamasheva, E. O'Donnell, C. Bandekar, A. Sofou, S. Heterogeneous liposome membranes with pH-triggered permeability enhance the in vitro antitumor activity of folate-receptor targeted liposomal doxorubicin. Mol Pharm, 8:2224-2232, . (PMID: 21899300)